Asparaginase erwinia chrysanthemi Intramuscular and Empliciti

• Generic Name: asparaginase erwinia chrysanthemi
• Dosage Forms: n.a.
• Other Brand Names: Erwinaze

Asparaginase Erwinia chrysanthemi is used together with other cancer medicines to treat a certain type of blood cancer called acute lymphoblastic leukemia (ALL). Asparaginase erwinia chrysanthemi is used in patients who have had an allergic reaction to E. coli-derived asparaginase.

Asparaginase Erwinia chrysanthemi belongs to the group of medicines known as antineoplastic agents. It interferes with the growth of the cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by asparaginase erwinia chrysanthemi, other effects will also occur. Some of these may be serious and must be reported to your doctor.

Before you begin treatment with Erwinaze®, you and your doctor should talk about the benefits of asparaginase erwinia chrysanthemi as well as the risks of using it.

Asparaginase erwinia chrysanthemi is to be given only by or under the immediate supervision of your doctor.

• Generic Name: elotuzumab
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Empliciti

Empliciti (elotuzumab) is a monoclonal antibody that blocks a certain protein in the body that can affect tumor cell growth. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.

Empliciti is used in combination chemotherapy to treat multiple myeloma (bone marrow cancer).

Empliciti is given together with either lenalidomide or pomalidomide, and a steroid medicine called dexamethasone.

Lenalidomide (Revlimid) is available only under a special program. You must be registered in the program and understand the risks and benefits of taking this medicine.